BiotechTube
Home/Keros Therapeutics/Jasbir S. Seehra, Ph.D.
JS

Jasbir S. Seehra, Ph.D.

President, Chief Executive Officer, and Director

Keros Therapeutics

Therapeutic Areas

HematologyMusculoskeletalPulmonaryMetabolic

Keros Therapeutics Pipeline

DrugIndicationPhase
KER-050 (Eltrapuldencel)Anemia in patients with myelodysplastic syndromes (MDS)Phase 2
KER-050Anemia in patients with myelofibrosisPhase 2
KER-012Pulmonary Arterial Hypertension (PAH)Phase 2
KER-065Obesity and related disordersPhase 1
KER-047Iron metabolism disordersPhase 1

Leadership Team at Keros Therapeutics

KR
Keith Regnante, CPA
Chief Financial Officer
SJ
Simon J. Cooper, M.B. B.Chir., M.Sc.
Chief Medical Officer
CR
Christopher R. Bowman, M.D.
Senior Vice President, Clinical Development
KB
Katherine Breedis
Vice President, General Counsel
JE
James E. Audia, Ph.D.
Chairman of the Board
JC
Julian C. Baker
Director
FJ
Felix J. Baker, Ph.D.
Director
CP
Christopher Peetz
Director
PJ
Pablo J. Cagnoni, M.D.
Director
JL
Jennifer L. Good
Director
View full Keros Therapeutics profile